Jörg J. Jacoby - Concepedia

Author

Jörg J. Jacoby

The University of Texas MD Anderson Cancer Center

Also Known As

J. J. Jacoby, Jörg J. Jacoby, Jörg J Jacoby, Jörg J. Jacoby

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center Heinrich Heine University Düsseldorf Yale University University of Maryland, College Park Shanghai Jiao Tong University

About

Jörg J. Jacoby is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, cell biology, and cell signaling.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	559
2	Biochemistry	3	3	136
3	Natural Sciences	2	2	102
4	Health Sciences	1	1	34
5	Public Health	1	1	30

Jörg J. Jacoby

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Cardiomyocyte-restricted knockout of STAT3 results in higher sensitivity to inflammation, cardiac fibrosis, and heart failure with advanced age Jörg J. Jacoby, April Kalinowski, Mu-Gen Liu, Proceedings of the National Academy of Sciences	2003	349
Upregulated stromal EGFR and vascular remodeling in mouse xenograft models of angiogenesis inhibitor–resistant human lung adenocarcinoma Tina Cascone, Matthew H. Herynk, Li Xu, Journal of Clinical Investigation Stromal EgfrMouse Xenograft ModelsAngiogenesis InhibitorsImmunologyPathology	2011	161
A screen for upstream components of the yeast protein kinase C signal transduction pathway identifies the product of the SLG1 gene Jörg J. Jacoby, Sigrid Nilius, Jürgen J. Heinisch Molecular and General Genetics MGG Signal TransductionFunctional GenomicsSignaling PathwayGeneticsSignal Recognition	1998	103
Effects of Medium- and Long-Chain Triacylglycerols on Lipid Metabolism and Gut Microbiota Composition in C57BL/6J Mice Shengmin Zhou, Yueqiang Wang, Jörg J. Jacoby, Journal of Agricultural and Food Chemistry	2017	88
Treatment with HIF-1α Antagonist PX-478 Inhibits Progression and Spread of Orthotopic Human Small Cell Lung Cancer and Lung Adenocarcinoma in Mice Jörg J. Jacoby, Baruch Erez, Maria Korshunova, Journal of Thoracic Oncology Tumor BiologyLung InflammationMedicineLung AdenocarcinomaImmunology	2010	81
Molecular Pharmacology and Antitumor Activity of PHT-427, a Novel Akt/Phosphatidylinositide-Dependent Protein Kinase 1 Pleckstrin Homology Domain Inhibitor Emmanuelle J. Meuillet, Zuohe Song, Robert Lemos, Molecular Cancer Therapeutics	2010	72
Combined MEK and VEGFR Inhibition in Orthotopic Human Lung Cancer Models Results in Enhanced Inhibition of Tumor Angiogenesis, Growth, and Metastasis Osamu Takahashi, Ritsuko Komaki, Paul D. Smith, Clinical Cancer Research	2012	70
Use of G-protein fusions to monitor integral membrane protein–protein interactions in yeast Kathleen N. Ehrhard, Jörg J. Jacoby, Xin‐Yuan Fu, Nature Biotechnology Membrane FusionProtein FunctionBiochemistryNatural SciencesMolecular Biology	2000	67
Mutants affected in the putative diacylglycerol binding site of yeast protein kinase C Jörg J. Jacoby, Hans‐Peter Schmitz, Jürgen J. Heinisch FEBS Letters Fungal Cell BiologyMolecular RegulationYeast Pkc1pMolecular BiologyPutative Diacylglycerol	1997	35
Evaluation of Novel Orthotopic Nude Mouse Models for Human Small-Cell Lung Cancer Takeshi Isobe, Amir Onn, Daniel Morgensztern, Journal of Thoracic Oncology Tumor BiologyOncologyMedicineBronchial NeoplasmTumor Targeting	2013	35

Page 1